Claims for Patent: 7,049,414

Summary for Patent: 7,049,414

Title:	Isolation of lectins
Abstract:	The invention relates to a process for isolating a lectin composition, in particular comprising the mannose-binding lectin (MBL), suitable for using recombinantly produced lectins as starting material, as well as methods for enriching a lectin preparation with respect to high molecular weight lectins. The method implies the use of sugar derivative modified solid supports, wherein the concentration of sugar derivatives on the solid support contributes to the isolation of predetermined oligomers of lectins.
Inventor(s):	Matthiesen; Finn (Bronshoj, DK)
Assignee:	Natimmune A/S (Copenhagen O, DK)
Application Number:	10/398,151
Patent Claims:	1. A method for isolating at least one lectin from a preparation comprising a variety of lectin molecules, comprising providing a solid support which is derivatized with a predetermined concentration of an amino sugar having a primary amino group, said amino sugar being coupled through the amino group to the solid support, applying the preparation to said solid support, allowing the lectins to bind to the sugar coupled to the solid support, washing the solid support, with a washing liquid removing unbound contaminants, and optionally recovering said lectin(s) from the solid support. 2. The method according to claim 1, wherein the amino sugar is selected from the group consisting of galactosamine, mannosamine, glucosamine, allosamine, altrosamine, ribosamine, arabinosamine, gulosamine, idosamine, fucosamine, talosamine, xylosamine, lyxosamine, sorbosamine, tagatosamine, psicosamine and fructosamine. 3. The method according to claim 1, wherein the amino sugar is selected from the group consisting of D-mannosamine, D-glucosamine, D-allosamine, D-altrosamine, D-ribosamine, D-arabinosamine, L-gulosamine, L-idosamine, L-galactosamine, L-fucosamine, L-talosamine, L-xylosamine and L-lyxosamine. 4. The method according to claim 1, wherein the amino sugar is selected from the group consisting of D-mannosamine and D-glucosamine. 5. The method according to claim 1, wherein the lectin is recovered from said solid support. 6. The method according to claim 5, wherein the lectin is recovered in substantially pure form. 7. The method according to claim 1, wherein the solid support is selected from the group consisting of chromatography columns, chromatographic resins, filters, plastic surfaces, glass surfaces and magnetic particles. 8. The method according to claim 7, wherein the column is selected from the group consisting of N-hydroxy succinimide activated resins, Cyanogen bromide activated resins, Epoxy activated resins, ECH Sepharose 4B from Amersham Biosciences and Activated CH-Sepharose 4B from Amersham Biosciences. 9. The method according to claim 7, wherein the plastic surface is an activated microtiter plate. 10. The method according to claim 1, wherein the lectin is mannose-binding lectin (MBL). 11. The method according to claim 1, wherein the washing liquid comprises one or more components selected from the group consisting of sugars capable of binding to the lectin, sugar derivatives capable of binding to the lectin and divalent metal ion chelating agents. 12. The method according to claim 11, wherein the sugar is selected from the group consisting of mannose, mannosamine, N-acetylmannosamine, glucose, glucosamine, N-acetylglucosamine, fructose, fructosamine, N-acetylfructosamine, galactose, galactosamine, N-acetylgalactosamine, saccharose and maltose. 13. A method for increasing the ratio R of a composition comprising a variety of lectin molecules, wherein R is the ratio of the concentration of lectin molecules having a high molecular weight above a predetermined molecular weight to the concentration of lectin molecules having a low molecular weight below or equal to the predetermined molecular weight, said method comprising obtaining a lectin preparation comprising low molecular weight lectin and high molecular weight lectin, said preparation having the ratio R=R.sub.0, applying the preparation to an isolation method as defined in claim 1, obtaining a composition comprising the recovered lectin molecules. 14. A method for producing a composition comprising a variety of lectin molecules, wherein substantially all of said lectin molecules have a molecular weight above a predetermined molecular weight for dimer lectins, said method comprising obtaining a lectin preparation comprising lectin molecules having a high molecular weight above the predetermined molecular weight and lectin molecules having a low molecular weight below or equal to the predetermined molecular weight, wherein the predetermined molecular weight is the molecular weight of dimeric mannose-binding lectin (MBL), which is about 200 kDa as determined by SDS-page, applying the method as defined in claim 1 to said preparation, obtaining a composition comprising the recovered lectin molecules. 15. A method for separating a composition comprising a variety of lectin molecules, wherein substantially all of said lectin molecules have a high molecular weight above a predetermined molecular weight, from a lectin preparation comprising lectin molecules having a high molecular weight above the predetermined molecular weight and lectin molecules having a low molecular weight below or equal to the molecular weight for dimer lectins, wherein the predetermined molecular weight is the molecular weight of dimeric mannose-binding lectin (MBL), which is about 200 kDa as determined by SDS-page, obtaining said lectin preparation, applying the method as defined in claim 1 to said preparation, obtaining a composition comprising the recovered lectin molecules. 16. A method for producing a composition comprising a variety of lectin molecules, wherein substantially all of said lectin molecules have a low molecular weight below or equal to a predetermined molecular weight, said method comprising obtaining a lectin preparation comprising lectin molecules having a high molecular weight above the predetermined molecular weight and lectin molecules having a low molecular weight below or equal to the predetermined molecular weight, applying the method as defined in claim 1 to said preparation, obtaining a composition comprising the unbound lectin molecules of the washing liquid. 17. A method of increasing the ratio R' of a preparation comprising a variety of lectin molecules, wherein R' is the ratio of the concentration of lectins having an intermediate molecular weight to the combined concentration of lectin molecules having a high molecular weight and a low molecular weight, wherein intermediate molecular weight is a molecular weight below a first predetermined molecular weight and above a second predetermined molecular weight, high molecular weight is a molecular weight above or equal to the first predetermined molecular weight and low molecular weight is a molecular weight below or equal to the second predetermined molecular weight, said method comprising the steps of a) obtaining a lectin preparation comprising low molecular weight lectin, intermediate molecular weight lectin and high molecular weight lectin, and b) applying the method as defined in claim 1 to said preparation; and c) obtaining a composition comprising the recovered lectin molecules whereby the value of the ratio R' for the composition of (c) is higher than the value of the ratio R' for the preparation of (a); and d) optionally repeating step b). 18. The method according to claim 13, wherein the lectin is mannose-binding lectin (MBL). 19. The method according to claim 18, wherein at least 50% of the high molecular weight MBL of the composition has a molecular weight above 200 kDa. 20. The method according to claim 18, wherein the low molecular weight MBL comprises MBL having a molecular weight below 200 kDa. 21. The method according to claim 1, wherein the lectin preparation is a recombinant mannose-binding lectin (MBL), preparation. 22. The method according to claim 21, wherein the MBL preparation is obtained by preparing a gene expression construct encoding human MBL peptide or a functional equivalent thereof, transforming a host cell culture with the construct, cultivating the host cell culture in a culture medium, thereby obtaining expression and secretion of the polypeptide into the culture medium, obtaining a preparation comprising a variety of MBL molecules. 23. The process according to claim 22, wherein the gene expression construct comprises at least one intron sequence from the human MBL gene or a functional equivalent thereof. 24. The process according to claim 23, wherein the gene expression construct comprises at least two exon sequences from the human MBL gene or a functional equivalent thereof. 25. The process according to claim 22, wherein the gene expression construct comprises a cDNA sequence encoding a MBL subunit or a functional equivalent thereof. 26. The process according to claim 22, wherein the host cell culture is cultured in vitro. 27. The process according to claim 22, wherein the host cell culture is a eukaryotic host cell culture. 28. The process according to claim 22, wherein the host cell culture is a mammalian host cell culture. 29. A solid support, wherein said solid support is a chromatography column resin, and wherein said solid support has, covalently coupled thereto, a predetermined concentration of 0.1 mg to 1000 mg amino sugar per ml resin, said amino sugar having a primary amino group, said amino sugar being coupled through the amino group to the solid support. 30. The solid support according to claim 29, wherein the amino sugar is selected from the group consisting of galactosamine, fucosamine, mannosamine, glucosamine, allosamine, altrosamine, ribosamine, arabinosamine, gulosamine, idosamine, galactosamine, talosamine, xylosamine, lyxosamine, sorbosamine, tagatosamine, psicosamine and fructosamine. 31. The solid support according to claim 29, wherein the solid support is selected from the group consisting of chromatography columns, chromatographic resins, filters, plastic surfaces, glass surfaces and magnetic particles. 32. The solid support according to claim 29, wherein the column is selected from the group consisting of N-hydroxy succinimide activated resins, Cyanogen bromide activated resins, Epoxy activated resins, ECH Sepharose 4B from APBiotech and Activated CH-Sepharose 4B from AP-Biotech. 33. A method for isolating at least one lectin from a preparation comprising a variety of lectin molecules, comprising providing a solid support which is derivatized with at least one amino sugar, said amino sugar having a primary amino group, applying the preparation to said solid support, allowing the lectins to bind to the amino sugar coupled to the solid support, washing the solid support with a washing liquid removing unbound contaminants, and optionally recovering said lectin(s) from the solid support. 34. The method according to claim 33, wherein the amino sugar is selected from the group consisting of galactosamine, mannosamine, glucosamine, allosamine, altrosamine, ribosamine, arabinosamine, gulosamine, idosamine, fucosamine, talosamine, xylosamine, lyxosamine, sorbosamine, tagatosamine, psicosamine and fructosamine. 35. The method according to claim 33, wherein the amino sugar is selected from the group consisting of D-mannosamine, D-glucosamine, D-allosamine, D-altrosamine, D-ribosamine, D-arabinosamine, L-gulosamine, L-idosamine, L-galactosamine, L-fucosamine, L-talosamine, L-xylosamine and L-lyxosamine. 36. The method according to claim 33, wherein the amino sugar is selected from the group consisting of D-mannosamine and D-glucosamine. 37. The method according to claim 33, wherein the lectin is recovered from said solid support. 38. The method according to claim 33, wherein the lectin is recovered in substantially pure form. 39. The method according to claim 33, wherein the solid support is selected from the group consisting of chromatography columns, chromatographic resins, filters, plastic surfaces, glass surfaces and magnetic particles. 40. The method according to claim 33, wherein the column is selected from the group consisting of N-hydroxy succinimide activated resins, Cyanogen bromide activated resins, Epoxy activated resins, ECH Sepharose 4B from Amersham Biosciences and Activated CH-Sepharose 4B from Amersham Biosciences. 41. The method according to claim 33, wherein the plastic surface is an activated microtiter plate. 42. The method according to claim 33, wherein the lectin is mannose-binding lectin (MBL). 43. The method according to claim 33, wherein the washing liquid comprises one or more components selected from the group consisting of sugars capable of binding to the lectin, sugar derivatives capable of binding to the lectin and divalent metal ion chelating agents. 44. The method according to claim 33, wherein the sugar is selected from the group consisting of mannose, mannosamine, N-acetylmannosamine, glucose, glucosamine, Nacetylglucosamine, fructose, fructosamine, N-acetylfructosamine, galactose, galactosamine, N-acetylgalactosamine, saccharose and maltose. 45. The method according to claim 1, wherein the amino sugar comprises an MBL binding site and the lectin is mannose-binding lectin (MBL). 46. The method of claim 14, wherein said composition comprising the recovered lectin molecules is further characterized by a ratio (R.sub.1) of the concentration of the lectin molecules having a molecular weight above the predetermined molecular weight, to the concentration of the lectin molecules having a concentration below the predetermined molecular weight, such that R.sub.1 is at least 1. 47. The method of claim 15, wherein said composition comprising the recovered lectin molecules is further characterized by a ratio (R.sub.1) of the concentration of the lectin molecules having a molecular weight above the predetermined molecular weight, to the concentration of the lectin molecules having a concentration below the predetermined molecular weight, such that R.sub.1 is at least 1.

Details for Patent 7,049,414

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2021-10-19
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2021-10-19
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2021-10-19